3 MUTANT SELECTIVITY AND COMBINATIONS OF A PHOSPHOINOSITIDE 3 KINASE INHIBITOR COMPOUND AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER
- 专利权人:
- 에프. 호프만-라 로슈 아게
- 发明人:
- 벨빈 마르시아,프리드만 로리,삼패스 디팩,월린 제프리
- 申请号：
- KR1020187029395
- 公开号：
- KR1019159420000B1
- 申请日:
- 2013.06.07
- 申请国别(地区):
- KR
- 年份:
- 2018
- 代理人:
- 摘要：
- The present invention relates to a method and composition for treating a hyperproliferative disorder in a patient using the PI3K inhibitor GDC-0032 as a single agent or in combination with a chemotherapeutic agent.본 발명은 PI3K 억제제인 GDC-0032를 단일 약제로서 또는 화학치료제와 함께 사용하여 환자에서 과다증식성 장애를 치료하는 방법 및 조성물에 관한 것이다.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- 3 MUTANT SELECTIVITY AND COMBINATIONS OF A PHOSPHOINOSITIDE 3 KINASE INHIBITOR COMPOUND AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER
- MUTANT SELECTIVITY AND COMBINATIONS OF A PHOSPHOINOSITIDE 3 KINASE INHIBITOR COMPOUND AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER
- Mutant selectivity and combinations of a phosphoinositide 3 Kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer
- Mutant selectivity and combinations of a phosphoinositide 3 kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer
- Mutant selectivity and combinations of a phosphoinositide 3 Kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer
